zoledronic acid has been researched along with Hepatocellular Carcinoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, BC; Han, M; Hwang, HJ; Hwang, S; Jung, DH; Kang, Y; Kim, M; Kim, N; Koh, KN; Song, GW; Tak, E | 1 |
| Fan, H; He, S; Li, B; Li, Z; Yang, T; Zhang, L | 1 |
| Cui, X; Lin, X; Wu, S | 1 |
| Cao, H; Nguyen, AL; Thinn, MM | 1 |
| Bai, RZ; Chang, SJ; Hua, D; Liu, Q; Tao, YH | 1 |
| Chai, ZT; Gao, DM; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Wang, L; Wang, WQ; Wu, WZ; Xu, HX; Zhang, JB; Zhang, W; Zhu, XD; Zhuang, PY | 1 |
| Natori, T; Yamaguchi, M | 1 |
| Abe, H; Aikata, H; Chayama, K; Hiraga, N; Honda, Y; Imamura, M; Kawaoka, T; Miki, D; Murakami, E; Ochi, H; Ono, A; Shi, N; Takahashi, S; Tsuge, M; Zhang, Y | 1 |
| Aoyama, Y; Morii, K; Nakamura, S; Okushin, H | 1 |
| Fujinami, N; Iwama, T; Kaneko, S; Nakatsura, T; Shimomura, M; Sugai, S; Tsuchiya, N; Ueda, N; Uemura, Y; Yoshikawa, T; Zhang, R | 1 |
| Addeo, R; Capasso, E; Caraglia, M; Cennamo, G; Del Prete, S; Faiola, V; Frega, N; Guarrasi, R; Leopardo, D; Maiorino, L; Mamone, R; Montella, L; Montesarchio, V; Palmieri, G; Pizza, C; Vincenzi, B | 1 |
| Kong, LQ; Sun, HC; Tang, ZY; Wang, L; Wu, WZ; Xiong, YQ; Xu, HX; Zhang, W; Zhu, XD; Zhuang, PY | 1 |
| Boudjema, K; Bouet-Toussaint, F; Cabillic, F; Catros, V; Daniel, P; de La Pintière, CT; Lavoué, V; Mönkkönen, H; Mönkkönen, J; Rioux-Leclerc, N; Toutirais, O; Turlin, B | 1 |
| Armeanu-Ebinger, S; Baeuerle, PA; Dewerth, A; Fuchs, J; Hoh, A; Vogt, F; Warmann, SW; Wenz, J | 1 |
1 trial(s) available for zoledronic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome; Zoledronic Acid | 2010 |
13 other study(ies) available for zoledronic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cytotoxicity, Immunologic; Diphosphates; Humans; Leukocytes, Mononuclear; Liver Neoplasms; Male; NK Cell Lectin-Like Receptor Subfamily K; Receptors, Antigen, T-Cell, gamma-delta; Zoledronic Acid | 2023 |
Study on the effect of γδ T cells expanded
Topics: Animals; Carcinoma, Hepatocellular; Leukocytes, Mononuclear; Liver Neoplasms; Mice; Mice, Nude; NK Cell Lectin-Like Receptor Subfamily K; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid | 2023 |
Effect of Liposome-Encapsulated Zoledronic Acid on Microenvironment of Hepatocellular Carcinoma May Depend on the Ratio Between M1 and M2 Polarized Macrophages.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Drug Compounding; Female; Humans; Liposomes; Liver Neoplasms; Mice; Mice, Inbred BALB C; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; RAW 264.7 Cells; Tumor Burden; Tumor Microenvironment; Tumor-Associated Macrophages; Xenograft Model Antitumor Assays; Zoledronic Acid | 2020 |
Metastatic Hepatocellular Carcinoma Treated With Zoledronic Acid.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Zoledronic Acid | 2018 |
Zoledronic acid inhibits growth of hepatocellular carcinoma cells in vitro and in vivo.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Diphosphonates; Female; Humans; Imidazoles; Liver Neoplasms; Mice; Xenograft Model Antitumor Assays; Zoledronic Acid | 2013 |
Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dendritic Cells; Diphosphonates; Heterografts; Humans; Imidazoles; Immunosuppression Therapy; Indoles; Interleukin-12 Subunit p40; Killer Cells, Natural; Liver Neoplasms; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; Zoledronic Acid | 2013 |
[Complete response after sorafenib therapy plus zoledronic acid for advanced hepatocellular carcinoma with bone metastasis - a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Diphosphonates; Humans; Imidazoles; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Remission Induction; Sorafenib; Zoledronic Acid | 2013 |
Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway.
Topics: Apoptosis; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Growth Processes; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Survival; Cytosol; Depression, Chemical; Diphosphonates; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Imidazoles; Liver Neoplasms; Mevalonic Acid; Mitogen-Activated Protein Kinases; Signal Transduction; Zoledronic Acid | 2015 |
Synergistic anti-tumor effects of zoledronic acid and radiotherapy against metastatic hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Biomarkers; Bone Neoplasms; Carcinoma, Hepatocellular; Combined Modality Therapy; Diphosphonates; Femoral Fractures; Humans; Imidazoles; Liver Cirrhosis; Liver Neoplasms; Macrophages; Male; Osteoclasts; Protein Precursors; Prothrombin; Severity of Illness Index; Zoledronic Acid | 2015 |
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
Topics: Antigens, Differentiation, T-Lymphocyte; Carcinoma, Hepatocellular; Cell Proliferation; Combined Modality Therapy; Cytotoxicity, Immunologic; Diphosphonates; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Imidazoles; Immunity, Innate; Liver Neoplasms; Lymphocyte Activation; T-Lymphocytes, Cytotoxic; Zoledronic Acid | 2016 |
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.
Topics: Angiogenesis Inhibitors; Animals; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Liposomes; Liver Neoplasms, Experimental; Lung Neoplasms; Macrophages; Male; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Xenograft Model Antitumor Assays; Zoledronic Acid | 2010 |
Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
Topics: Adenocarcinoma; Aged; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Coculture Techniques; Colorectal Neoplasms; Cytotoxicity, Immunologic; Dendritic Cells; Diphosphates; Diphosphonates; Female; Flow Cytometry; Hemiterpenes; Humans; Imidazoles; Immunotherapy, Adoptive; Liver Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Zoledronic Acid | 2010 |
The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.
Topics: Antibodies, Bispecific; Antigens, Neoplasm; Carcinoma, Hepatocellular; CD3 Complex; Cell Adhesion Molecules; Cell Line, Tumor; Cell Survival; Coculture Techniques; Cytotoxicity, Immunologic; Diphosphonates; Epithelial Cell Adhesion Molecule; Hepatoblastoma; Histone Deacetylase Inhibitors; Humans; Imidazoles; Liver Neoplasms; Lymphocyte Activation; Microscopy, Fluorescence; Receptors, Antigen, T-Cell, gamma-delta; Single-Chain Antibodies; Spheroids, Cellular; T-Lymphocytes; Zoledronic Acid | 2013 |